What question did this study set out to answer?

To investigate the prevalence, risk factors, and spectrum of bacterial coinfections in COVID-19 ICU patients.

January 17, 2026Immunology

Bacterial Coinfection in Critically Ill Patients With COVID ‐19

View Full Paper

Ask AI

Bookmark

To investigate the prevalence, risk factors, and spectrum of bacterial coinfections in COVID-19 ICU patients.
Retrospective cohort study using data from ICU COVID-19 patients
Analyzed 201 patients admitted from March 2020 to July 2021
Assessed prevalence, risk factors, and causative agents of coinfections
Compared data with related studies and reviews
70% of patients developed bacterial coinfections
Most common were VAP (47.5% prevalence), followed by BSI and CA-UTI
Prolonged ventilatory support and ICU stay linked to increased infection risk
Klebsiella pneumoniae and Staphylococcus aureus identified as predominant pathogens
Extended spectrum beta-lactamases found in Klebsiella pneumoniae in 121 cases

No takes yet. Share an insight, caveat, or question.

Single-centre cohort study investigates bacterial coinfection prevalence in ICU COVID-19 patients, suggesting the need for enhanced monitoring.

Bartoszewicz et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Single-centre cohort study investigates bacterial coinfection prevalence in ICU COVID-19 patients, suggesting the need for enhanced monitoring.